1️⃣ Although conventional treatments show modest benefits, pilot and phase I/II trials with bone marrow (BM) and adipose-derived (AD) mesenchymal stromal cells (MSCs) point to the feasibility, safety, and occurrence of clinical and structural improvement in focal or diffuse disease.

2️⃣This study aimed to assess the safety and efficacy of the intra-articular injection of single or repeated umbilical cord-derived (UC) MSCs in knee OA.

3️⃣ At 12 months, Western Ontario and Mc Master Universities Arthritis Index (WOMAC-A; pain subscale) reached significantly lower levels of pain in the MSC-2-treated group as compared with the HA group. Pain Visual Analog scale was significantly lower in the MSC-2 group versus the HA group at 12 months.


[By Celebre Pro Medic Sdn Bhd 20211119]

Leave a Reply

Your email address will not be published. Required fields are marked *